Australia markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
109.67+0.84 (+0.77%)
At close: 04:00PM EDT
109.01 -0.66 (-0.60%)
After hours: 06:50PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
414,832
414,832
-224,060
-329,668
238,616
Depreciation & amortisation
638,696
638,696
629,471
552,483
278,253
Deferred income taxes
-260,217
-260,217
-292,251
69,198
-136,937
Stock-based compensation
226,841
226,841
221,996
189,006
120,998
Change in working capital
-204,439
-204,439
9,905
-47,952
-85,437
Accounts receivable
-51,883
-51,883
-90,135
-92,735
-38,647
Inventory
-13,420
-13,420
-49,642
-48,861
-30,537
Accounts payable
9,603
9,603
-11,225
57,021
-18,935
Other working capital
1,049,045
1,049,045
773,783
732,975
520,394
Other non-cash items
204,167
204,167
741,027
325,772
327,578
Net cash provided by operating activities
1,092,007
1,092,007
1,271,977
778,507
899,648
Cash flows from investing activities
Investments in property, plant and equipment
-42,962
-42,962
-498,194
-45,532
-379,254
Acquisitions, net
0
0
0
-6,234,792
0
Purchases of investments
-390,100
-390,100
-61,036
-26,819
-2,397,675
Sales/maturities of investments
270,000
270,000
60,000
1,095,000
1,755,000
Other investing activities
-
-
-
-
14,259
Net cash used for investing activities
-163,062
-163,062
-446,230
-5,212,143
-1,007,670
Cash flows from financing activities
Debt repayment
-31,000
-31,000
-582,014
-1,320,600
-889,575
Common stock repurchased
-269,761
-269,761
-54
0
-146,537
Other financing activities
-50,952
-50,952
-45,443
-35,602
-16,877
Net cash used provided by (used for) financing activities
-305,254
-305,254
-529,491
3,970,522
528,073
Net change in cash
624,828
624,828
290,034
-466,321
420,425
Cash at beginning of period
881,482
881,482
591,448
1,057,769
637,344
Cash at end of period
1,506,310
1,506,310
881,482
591,448
1,057,769
Free cash flow
Operating cash flow
1,092,007
1,092,007
1,271,977
778,507
899,648
Capital expenditure
-42,962
-42,962
-498,194
-45,532
-379,254
Free cash flow
1,049,045
1,049,045
773,783
732,975
520,394